KIAA1045 inhibitors are a class of chemical compounds designed to target and modulate the function of the KIAA1045 protein, a gene product that plays a role in cellular processes that are not yet fully elucidated. KIAA1045 is encoded by the KIAA1045 gene, which has been identified through large-scale cDNA sequencing projects. The protein it encodes is predicted to be involved in the regulation of various intracellular mechanisms, possibly related to the cytoskeleton or signaling pathways, given its structural domains. However, the precise biochemical pathways influenced by KIAA1045 remain under active investigation, and the inhibitors targeting this protein aim to interrupt its function, thereby allowing researchers to investigate its role further.
The design of KIAA1045 inhibitors involves structural analogs that can bind to specific domains of the KIAA1045 protein, thereby inhibiting its function. These inhibitors are typically small molecules synthesized to ensure high specificity, aiming to avoid off-target effects that could interfere with other proteins or pathways. Detailed structural studies, including X-ray crystallography or molecular modeling, are often employed to optimize the binding efficiency of these inhibitors. Research into KIAA1045 inhibitors is motivated by a desire to unravel the fundamental cellular mechanisms controlled by the KIAA1045 protein and to understand its role in processes such as gene expression regulation, protein interaction, and potential effects on cell morphology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can alter gene expression, possibly affecting KIAA1045 expression if its regulation is histone modification-dependent. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can alter DNA methylation status, potentially affecting the expression of genes including KIAA1045. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glycolysis inhibitor that may affect energy metabolism and indirectly influence proteins associated with metabolic processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomotropic agent that can alter endosomal and lysosomal pH, potentially affecting proteins involved in these cellular compartments. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can affect protein turnover, potentially influencing the stability and function of KIAA1045 if it is degraded by the proteasome. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Hsp90 inhibitor that can affect protein folding and stability, potentially influencing client proteins including KIAA1045. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can affect the MAPK/ERK pathway, potentially influencing proteins regulated by this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect the AKT signaling pathway, potentially influencing proteins regulated by this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can affect cell growth and autophagy, potentially influencing proteins involved in these processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that disrupts calcium homeostasis, potentially affecting proteins involved in calcium signaling. | ||||||